AGP Picks
View all

Bioabsorbable surgical fixation devices market seen reaching $1.56B by 2030

Oct. 19, 2026
Bioabsorbable surgical fixation devices market seen reaching $1.56B by 2030
By AI, Created 16:15 UTC, Oct 19, 2026, AGP -

The Business Research Company projects steady growth in the bioabsorbable surgical fixation devices market, driven by rising orthopedic injuries, more minimally invasive surgery and demand for implants that do not need removal. The report says the market could grow from $1.18 billion in 2025 to $1.56 billion by 2030, with North America leading in 2025 and Asia-Pacific expected to grow fastest.

Why it matters: - Bioabsorbable surgical fixation devices can reduce the need for follow-up surgery because the implant dissolves after the bone or tissue heals. - The devices are gaining traction as hospitals and surgeons seek less invasive orthopedic treatments, faster recovery and lower overall care costs. - The market outlook suggests continued demand for biodegradable medical materials in fracture repair, ligament repair and sports medicine.

What happened: - The Business Research Company released its Bioabsorbable Surgical Fixation Devices Market Report 2026, covering market size, trends and a global forecast for 2026-2035. - The report estimates the market will rise from $1.18 billion in 2025 to $1.24 billion in 2026. - The report projects the market will reach $1.56 billion by 2030. - The report puts the market on a 5.6% CAGR from 2025 to 2026 and a 5.8% CAGR through 2030. - The company published a free sample of the report More information.

The details: - Bioabsorbable surgical fixation devices are temporary implants made from biodegradable polymers. - The devices stabilize fractured bones, repaired ligaments and other musculoskeletal tissues during healing. - The implants gradually break down into biocompatible substances that the body metabolizes or eliminates. - The report says the main growth drivers include orthopedic injuries and fractures, growing use of minimally invasive surgery, preference for implants that do not require removal, broader use of biodegradable medical materials and efforts to reduce postoperative complications. - The report also points to stronger demand for musculoskeletal tissue healing, wider use in sports medicine, improved patient comfort, broader use in ligament and bone repair and lower costs tied to implant removal surgery. - The report says trends shaping the market include more adoption in orthopedic treatments, more temporary fixation options, greater use of biodegradable polymers for tissue stabilization and more minimally invasive procedures. - A section on minimally invasive surgery says smaller incisions and specialized instruments can reduce tissue trauma, pain, hospital stays and recovery time compared with open surgery. - NHS England reported in June 2025 that about 70,000 robot-assisted minimally invasive surgeries were performed across the NHS during 2023-24. - NHS England plans to raise that number to 500,000 a year by 2035 and wants 90% of eligible keyhole surgeries to be robot-assisted. - North America held the largest share of the global market in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, plus updated graphics and tables. - The release includes contact details for Saumya Sahay and Oliver Guirdham, along with phone numbers, email and social media links.

Between the lines: - The forecast reflects a broader shift in surgery toward devices that support healing without requiring later removal. - The NHS robotics targets suggest a larger pipeline of minimally invasive procedures, which could support demand for temporary fixation products. - The regional split signals a mature North American base and a growth runway in Asia-Pacific.

What's next: - The market’s next phase will likely be shaped by orthopedic procedure volumes, adoption of robot-assisted and minimally invasive surgery, and wider use of biodegradable materials. - The Business Research Company’s forecasting tools and regional analysis suggest the firm expects buyers and suppliers to track market hotspots more closely as the category expands. - More information is available in the full report.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

News Center UK

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

News Center UK

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.